CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 125 of 137 entries

View as:

Reducing Pacemaker Implantation After TAVR With Modified Implantation Technique

Phase: N/A Priority: Normal

NCT ID: NCT04734392 Org: User:

Start: 01/01/20 End: 11/28/23 Due: 11/28/24

Effect of Long Chain Polyunsaturated Fatty Acids on Behavior and Cognition in Children With Attention Deficit Hyperactivity Disorder

Phase: N/A Priority: Normal

NCT ID: NCT01055119 Org: User:

Start: 04/30/09 End: 09/30/12 Due: 09/30/13

Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis

Phase: N/A Priority: Normal

NCT ID: NCT03044223 Org: User:

Start: 08/31/14 End: 12/31/26 Due: 12/31/27

Bougiecap for Treatment of Benign Stenosis in GI Tract

Phase: N/A Priority: Normal

NCT ID: NCT03349021 Org: User:

Start: 02/01/18 End: 09/01/18 Due: 09/01/19

Burden, Mortality and Supply Costs in Intensive Care Unit Patients

Phase: N/A Priority: Normal

NCT ID: NCT04094428 Org: User:

Start: 10/21/19 End: 09/30/26 Due: 09/30/27

Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine

Phase: N/A Priority: Normal

NCT ID: NCT01180322 Org: User:

Start: 11/30/10 End: 10/02/16 Due: 10/02/17

Magnetic Resonance Adenosine Perfusion Imaging as Gatekeeper of Invasive Coronary Intervention

Phase: N/A Priority: Normal

NCT ID: NCT02580851 Org: User:

Start: 12/31/11 End: 02/28/18 Due: 02/28/19

Fast Track Management in Elective Open Infrarenal Aortic Aneurysm Repair

Phase: N/A Priority: Normal

NCT ID: NCT00615888 Org: User:

Start: 09/30/05 End: 03/31/08 Due: 03/31/09

Study of Palbociclib in MLL-rearranged Acute Leukemias

Phase: N/A Priority: Normal

NCT ID: NCT02310243 Org: User:

Start: 07/31/15 End: 07/31/19 Due: 07/31/20

Critically Ill ICU Patients Under Casirivimab- and/or Tocilizumab Application

Phase: N/A Priority: Normal

NCT ID: NCT06233357 Org: User:

Start: 08/01/21 End: 12/31/23 Due: 12/31/24

Lenalidomide In Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal

NCT ID: NCT00839059 Org: User:

Start: 01/31/09 End: 05/31/11 Due: 05/31/12

Understanding Individual Variability in Neuronal Signal Transmission to Target Organs in Health and Disease

Phase: N/A Priority: Normal

NCT ID: NCT06912048 Org: User:

Start: 05/14/25 End: 05/31/27 Due: 05/31/28

App-based Symptom Tracking After Corona Vaccination (CoCoV)

Phase: N/A Priority: Normal

NCT ID: NCT04686409 Org: User:

Start: 01/11/21 End: 08/31/22 Due: 08/31/23

Hilotherapy for Prevention of Chemotherapy-induced Peripheral Polyneuropathy

Phase: N/A Priority: Normal

NCT ID: NCT06627348 Org: User:

Start: 04/17/24 End: 03/31/27 Due: 03/31/28

Early Versus Late Enteral Iron in Infants Less Than 1301 Grams

Phase: N/A Priority: Normal

NCT ID: NCT00458068 Org: User:

Start: 06/30/96 End: 09/30/99 Due: 09/30/00

Hemophagocytosis in Critically Ill Adult Patients

Phase: N/A Priority: Normal

NCT ID: NCT01913938 Org: User:

Start: 07/31/13 End: 12/31/26 Due: 12/31/27

Registry for Patients With Lipodystrophy

Phase: N/A Priority: Normal

NCT ID: NCT03553420 Org: User:

Start: 12/16/17 End: 01/31/68 Due: 01/31/69

Coronary and Structural Interventions Ulm - Bioresorbable Vascular Scaffold

Phase: N/A Priority: Normal

NCT ID: NCT02162056 Org: User:

Start: 11/30/13 End: 12/31/18 Due: 12/31/19

Pembrolizumab in MarginalzoneLymphoma a MULTICENTER OPEN LABEL SINGLE-ARM PHASE II STUDY

Phase: N/A Priority: Normal

NCT ID: NCT04268277 Org: User:

Start: 03/01/22 End: 12/06/24 Due: 12/06/25

Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MF

Phase: N/A Priority: Normal

NCT ID: NCT01644110 Org: User:

Start: 08/31/13 End: 04/27/24 Due: 04/27/25

The Influence of Having Breakfast on Cognitive Performance and Mood

Phase: N/A Priority: Normal

NCT ID: NCT00556868 Org: User:

Start: 10/31/05 End: 12/31/05 Due: 12/31/06

Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations

Phase: N/A Priority: Normal

NCT ID: NCT02298166 Org: User:

Start: 11/17/16 End: 03/09/20 Due: 03/09/21

Effects of Automated Adjustment of FiO2 on Cerebral and Arterial Oxygenation in Preterm Infants

Phase: N/A Priority: Normal

NCT ID: NCT01942473 Org: User:

Start: 08/31/12 End: 04/30/14 Due: 04/30/15

Concentration of Ertapenem in Colorectal Tissue

Phase: N/A Priority: Normal

NCT ID: NCT00535652 Org: User:

Start: 09/30/07 End: 12/31/09 Due: 12/31/10

A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma

Phase: N/A Priority: Normal

NCT ID: NCT02770378 Org: User:

Start: 11/30/16 End: 12/31/20 Due: 12/31/21

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Reducing Pacemaker Implantation After TAVR With Modified Implantation Technique	NCT04734392	University of Ulm	user2@example.com	None	2020-01-01	2023-11-28	2024-11-28	-	-	2025-07-14
Effect of Long Chain Polyunsaturated Fatty Acids on Behavior and Cognition in Children With Attention Deficit Hyperactivity Disorder	NCT01055119	University of Ulm	user2@example.com	None	2009-04-30	2012-09-30	2013-09-30	-	-	2025-07-14
Monocyte Profiles in Critically Ill Patients With Pseudomonas Aeruginosa Sepsis	NCT03044223	University of Ulm	user2@example.com	None	2014-08-31	2026-12-31	2027-12-31	-	-	2025-07-14
Bougiecap for Treatment of Benign Stenosis in GI Tract	NCT03349021	University of Ulm	user2@example.com	None	2018-02-01	2018-09-01	2019-09-01	-	-	2025-07-14
Burden, Mortality and Supply Costs in Intensive Care Unit Patients	NCT04094428	University of Ulm	user2@example.com	None	2019-10-21	2026-09-30	2027-09-30	-	-	2025-07-14
Trial Evaluating Induction Therapy With Idarubicin and Etoposide Plus Sequential or Concurrent Azacitidine and Maintenance Therapy With Azacitidine	NCT01180322	University of Ulm	user2@example.com	None	2010-11-30	2016-10-02	2017-10-02	-	-	2025-07-14
Magnetic Resonance Adenosine Perfusion Imaging as Gatekeeper of Invasive Coronary Intervention	NCT02580851	University of Ulm	user2@example.com	None	2011-12-31	2018-02-28	2019-02-28	-	-	2025-07-14
Fast Track Management in Elective Open Infrarenal Aortic Aneurysm Repair	NCT00615888	University of Ulm	user2@example.com	None	2005-09-30	2008-03-31	2009-03-31	-	-	2025-07-14
Study of Palbociclib in MLL-rearranged Acute Leukemias	NCT02310243	University of Ulm	user2@example.com	None	2015-07-31	2019-07-31	2020-07-31	-	-	2025-07-14
Critically Ill ICU Patients Under Casirivimab- and/or Tocilizumab Application	NCT06233357	University of Ulm	user2@example.com	None	2021-08-01	2023-12-31	2024-12-31	-	-	2025-07-14
Lenalidomide In Patients With Acute Myeloid Leukemia	NCT00839059	University of Ulm	user2@example.com	None	2009-01-31	2011-05-31	2012-05-31	-	-	2025-07-14
Understanding Individual Variability in Neuronal Signal Transmission to Target Organs in Health and Disease	NCT06912048	University of Ulm	user2@example.com	None	2025-05-14	2027-05-31	2028-05-31	-	-	2025-07-14
App-based Symptom Tracking After Corona Vaccination (CoCoV)	NCT04686409	University of Ulm	user2@example.com	None	2021-01-11	2022-08-31	2023-08-31	-	-	2025-07-14
Hilotherapy for Prevention of Chemotherapy-induced Peripheral Polyneuropathy	NCT06627348	University of Ulm	user2@example.com	None	2024-04-17	2027-03-31	2028-03-31	-	-	2025-07-14
Early Versus Late Enteral Iron in Infants Less Than 1301 Grams	NCT00458068	University of Ulm	user2@example.com	None	1996-06-30	1999-09-30	2000-09-30	-	-	2025-07-14
Hemophagocytosis in Critically Ill Adult Patients	NCT01913938	University of Ulm	user2@example.com	None	2013-07-31	2026-12-31	2027-12-31	-	-	2025-07-14
Registry for Patients With Lipodystrophy	NCT03553420	University of Ulm	user2@example.com	None	2017-12-16	2068-01-31	2069-01-31	-	-	2025-07-14
Coronary and Structural Interventions Ulm - Bioresorbable Vascular Scaffold	NCT02162056	University of Ulm	user2@example.com	None	2013-11-30	2018-12-31	2019-12-31	-	-	2025-07-14
Pembrolizumab in MarginalzoneLymphoma a MULTICENTER OPEN LABEL SINGLE-ARM PHASE II STUDY	NCT04268277	University of Ulm	user2@example.com	None	2022-03-01	2024-12-06	2025-12-06	-	-	2025-07-14
Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MF	NCT01644110	University of Ulm	user2@example.com	None	2013-08-31	2024-04-27	2025-04-27	-	-	2025-07-14
The Influence of Having Breakfast on Cognitive Performance and Mood	NCT00556868	University of Ulm	user2@example.com	None	2005-10-31	2005-12-31	2006-12-31	-	-	2025-07-14
Study of Crenolanib in Combination With Chemotherapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia and Activating FLT3 Mutations	NCT02298166	University of Ulm	user2@example.com	None	2016-11-17	2020-03-09	2021-03-09	-	-	2025-07-14
Effects of Automated Adjustment of FiO2 on Cerebral and Arterial Oxygenation in Preterm Infants	NCT01942473	University of Ulm	user2@example.com	None	2012-08-31	2014-04-30	2015-04-30	-	-	2025-07-14
Concentration of Ertapenem in Colorectal Tissue	NCT00535652	University of Ulm	user2@example.com	None	2007-09-30	2009-12-31	2010-12-31	-	-	2025-07-14
A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma	NCT02770378	University of Ulm	user2@example.com	None	2016-11-30	2020-12-31	2021-12-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance